Stock Analiz

Amn Healthcare Services Inc. AMN

Professional Services · data as of November 13, 2026

$38.02Market cap $1.5B
Open the interactive analysis →

Amn Healthcare Services Inc. (AMN) is a consumer discretionary company listed in the US with a market value of about $1.5B. In the twelve months to September 30, 2026 it had revenue of $3.5B and net income of $109M, a net margin of 3.1%.

Its overall Stock Analiz score is 1.4 out of 5 (weak). The strongest part is value (3/5); the weakest is future growth (0/5).

Key numbers: a P/E of 13.8, a price to free cash flow of 4.5, 5-year revenue growth of 3% a year, a 5-year average ROIC of 9%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 46% below the current price.

Score: 1.4 / 5

Value3/5
Future growth0/5
Track record0/5
Financial health2/5
Shareholder returns2/5

Checks passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Positive free cash flow
  • Debt below 3 years of free cash flow
  • Share count down over 3 years (buybacks)
  • Stock-based pay below 5% of revenue

Checks not passed

  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • 3-year free cash flow growth above 10% a year
  • Strong R&D investment or growth above 20%
  • 5-year EPS growth above 10% a year

Valuation

P/E (TTM)13.8
Forward P/E45.6
P/FCF4.5
P/S0.4
P/B1.9
EV/EBITDA5.8
PEG—
Dividend yield0.00%
FCF yield22.3%
Shareholder yield0.0%
Intrinsic value vs. price−46%

Growth and quality

Revenue growth (1 yr)-8.5%
Revenue growth (5 yrs, per year)2.7%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)-26.0%
Net margin (5-yr avg.)2.8%
ROIC (5-yr avg.)9.0%
Profitable years (of last 10)8
Years paying a dividend—

Financials, last 10 years

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$3.5B$2.7B$3.0B$3.8B$5.2B$4.0B$2.4B$2.2B$2.1B$2.0B$1.9B
Net income$109M-$96M-$147M$211M$444M$327M$71M$114M$142M$133M$106M
Free cash flow$327M$234M$240M$268M$578M$252M$219M$190M$192M$134M$112M
EPS (diluted)$2.76$-2.48$-3.85$5.36$9.90$6.81$1.48$2.40$2.91$2.68$2.15
Net margin3.1%-3.5%-4.9%5.6%8.5%8.2%2.9%5.1%6.6%6.7%5.6%
ROIC—-3.6%-4.9%11.5%24.9%17.4%6.5%9.3%12.9%16.6%14.2%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 7 analysts is $44.79, 18% above the current price; targets range from $34.00 to $52.00; the consensus rating is “Hold”; expected EPS is $4.19 for the fiscal year ending December 31, 2026.

Frequently asked questions

What is Amn Healthcare Services’s P/E ratio?

About 13.8, based on the last twelve months of diluted earnings per share (forward P/E about 45.6).

Is Amn Healthcare Services stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 46% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Amn Healthcare Services pay a dividend?

Not currently.

Is Amn Healthcare Services a good stock to buy?

We do not give buy or sell advice. Amn Healthcare Services scores 1.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.